UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.51B |
| 2 |
Accenture
ACN
|
+$1.43B |
| 3 |
Linde
LIN
|
+$1.18B |
| 4 |
Prologis
PLD
|
+$1.06B |
| 5 |
Microsoft
MSFT
|
+$908M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$784M |
| 3 |
Blackrock
BLK
|
+$737M |
| 4 |
Meta Platforms (Facebook)
META
|
+$506M |
| 5 |
UBS Group
UBS
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.2% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRGX
2676
DELISTED
CARGO Therapeutics
CRGX
| $208K | ﹤0.01% |
11,262
-1,772
| -14% | -$31.7K |
|
2677
Brown-Forman Class A
BF.A
$13.8B
| $204K | ﹤0.01% |
+4,238
| New | +$191K |
|
2678
AMC Global Media
AMCX
$459M
| $203K | ﹤0.01% |
23,356
-6,888
| -23% | -$66.5K |
|
2679
Nuveen Credit Strategies Income Fund
JQC
$707M
| $203K | ﹤0.01% |
35,000
-25,000
| -42% | -$142K |
|
|
NCV
2680
Virtus Convertible & Income Fund
NCV
$372M
| $193K | ﹤0.01% |
13,750
-11,250
| -45% | -$153K |
|
|
GHY
2681
PGIM Global High Yield Fund
GHY
$477M
| $192K | ﹤0.01% |
15,000
-10,000
| -40% | -$124K |
|
2682
Lexicon Pharmaceuticals
LXRX
$1.04B
| $189K | ﹤0.01% |
+120,387
| New | +$214K |
|
2683
Root
ROOT
$911M
| $187K | ﹤0.01% |
4,962
-1,228
| -20% | -$63.4K |
|
|
FAX
2684
abrdn Asia-Pacific Income Fund
FAX
$593M
| $174K | ﹤0.01% |
10,000
-10,833
| -52% | -$182K |
|
|
NKLA
2685
DELISTED
Nikola Corporation Common Stock
NKLA
| $172K | ﹤0.01% |
37,642
-4,097
| -10% | -$30.3K |
|
|
CLCO
2686
DELISTED
Cool Company
CLCO
| $163K | ﹤0.01% |
14,456
-96
| -0.7% | -$1.12K |
|
|
MOMO
2687
Hello Group
MOMO
$872M
| $160K | ﹤0.01% |
21,030
+10,818
| +106% | +$71.7K |
|
2688
BRC Group Holdings
RILY
$267M
| $151K | ﹤0.01% |
28,677
-2,772
| -9% | -$30.8K |
|
2689
Similarweb
SMWB
$632M
| $141K | ﹤0.01% |
15,912
-3,138
| -16% | -$24.8K |
|
2690
Monte Rosa Therapeutics
GLUE
$1.83B
| $128K | ﹤0.01% |
24,100
+8,500
| +54% | +$42.9K |
|
|
CRDL
2691
Cardiol Therapeutics
CRDL
$136M
| $109K | ﹤0.01% |
55,000
| – | – |
|
2692
Suzano
SUZ
$10.4B
| $107K | ﹤0.01% |
+10,686
| New | +$104K |
|
|
OKLO
2693
Oklo
OKLO
$6.67B
| $104K | ﹤0.01% |
+12,881
| New | +$97K |
|
2694
1stdibs.com
DIBS
$151M
| $103K | ﹤0.01% |
23,361
| – | – |
|
2695
Holley
HLLY
$336M
| $97.9K | ﹤0.01% |
33,183
-16,812
| -34% | -$56.3K |
|
2696
Absci
ABSI
$1.19B
| $91.1K | ﹤0.01% |
23,850
| – | – |
|
2697
Bilibili
BILI
$7.83B
| $82.5K | ﹤0.01% |
3,528
+735
| +26% | +$11.4K |
|
2698
Black Diamond Therapeutics
BDTX
$98M
| $80.9K | ﹤0.01% |
18,600
| – | – |
|
|
JKS
2699
JinkoSolar
JKS
$783M
| $64.4K | ﹤0.01% |
2,400
-5,761
| -71% | -$116K |
|
|
VNET
2700
VNET Group
VNET
$1.82B
| $60.9K | ﹤0.01% |
14,931
| – | – |
|
Similar funds
UBS AM's Q3 2024 Portfolio in Review
As of Q3 2024, UBS AM held 2,899 positions worth $389B, up 12% from $349B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
UBS AM deployed $20.6B of net new capital in Q3 2024, opening 104 new positions and adding to 979 existing holdings. Its largest new stake was Cemex: 31,204,197 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $818M trimmed.
- UBS AM's largest Q3 2024 buy was Cemex: 31,204,197 shares worth $190M.
- UBS AM added most to Pinduoduo in Q3 2024, an estimated $1.51B increase.
- UBS AM's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $818M.
- UBS AM fully exited Vanguard Russell 1000 Growth ETF in Q3 2024, selling an estimated $128M.
- UBS AM's ten largest holdings make up 29% of its $389B portfolio in Q3 2024.
- UBS AM opened 104 new positions and closed 100 in Q3 2024.
- UBS AM's portfolio value rose 12% quarter-over-quarter to $389B.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.